We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
-13.66%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
-$27.2M
Cap. Flow
-$6.98M
Cap. Flow %
-5.92%
Top 10 Hldgs %
41.5%
Holding
126
New
4
Increased
39
Reduced
62
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 14.78%
2 Financials 14.41%
3 Healthcare 6.59%
4 Communication Services 4.13%
5 Consumer Discretionary 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLK icon
26
Blackrock
BLK
$176B
$1.25M 1.06%
2,051
-135
-6% -$87.9K
CWB icon
27
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.72B
$1.22M 1.04%
18,966
+954
+5% +$66.2K
VFH icon
28
Vanguard Financials ETF
VFH
$13.7B
$1.22M 1.03%
15,744
-351
-2% -$29.6K
WAT icon
29
Waters Corp
WAT
$38.3B
$1.19M 1.01%
3,582
-2,100
-37% -$667K
WELL icon
30
Welltower
WELL
$165B
$1.15M 0.97%
13,937
-232
-2% -$20.6K
VZ icon
31
Verizon
VZ
$193B
$1.12M 0.95%
22,061
-1,303
-6% -$65.9K
KO icon
32
Coca-Cola
KO
$371B
$1.12M 0.95%
17,745
-612
-3% -$38.8K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.07M 0.91%
3,926
-142
-3% -$44.5K
PFE icon
34
Pfizer
PFE
$141B
$978K 0.83%
18,646
-1,249
-6% -$63.6K
PHO icon
35
Invesco Water Resources ETF
PHO
$2.05B
$969K 0.82%
20,955
+652
+3% +$31.8K
VB icon
36
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
$831K 0.7%
4,716
-140
-3% -$27K
SPY icon
37
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$829K 0.7%
2,198
+30
+1% +$12.3K
IBB icon
38
iShares Biotechnology ETF
IBB
$9.23B
$818K 0.69%
6,956
-742
-10% -$88.1K
PG icon
39
Procter & Gamble
PG
$340B
$806K 0.68%
5,606
-142
-2% -$21.3K
DVY icon
40
iShares Select Dividend ETF
DVY
$23.5B
$797K 0.68%
6,774
+41
+0.6% +$5.13K
BMY icon
41
Bristol-Myers Squibb
BMY
$132B
$796K 0.68%
10,341
-4,744
-31% -$361K
EBC icon
42
Eastern Bankshares
EBC
$5.35B
$751K 0.64%
40,684
VXUS icon
43
Vanguard Total International Stock ETF
VXUS
$158B
$713K 0.6%
13,807
-2,773
-17% -$154K
VO icon
44
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$697K 0.59%
14,164
-1,316
-9% -$71.1K
GS icon
45
Goldman Sachs
GS
$312B
$688K 0.58%
2,317
-7
-0.3% -$2.18K
XLV icon
46
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
$680K 0.58%
5,300
-7
-0.1% -$918
FTCS icon
47
First Trust Capital Strength ETF
FTCS
$7.84B
$671K 0.57%
9,601
-1,184
-11% -$87K
VYM icon
48
Vanguard High Dividend Yield ETF
VYM
$81.8B
$637K 0.54%
6,265
+671
+12% +$72.7K
VIG icon
49
Vanguard Dividend Appreciation ETF
VIG
$113B
$635K 0.54%
4,426
+36
+0.8% +$5.48K
XLP icon
50
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$623K 0.53%
8,626
+180
+2% +$13.5K

Similar funds

O'Rourke & Company's Q2 2022 Portfolio in Review

As of Q2 2022, O'Rourke & Company held 126 positions worth $118M, down 19% from $145M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

O'Rourke & Company withdrew a net $6.98M in Q2 2022, closing 12 positions and reducing 62 holdings. Its most notable exit was Coinbase, an estimated $510K position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, O'Rourke & Company opened a new position in Vanguard Tax-Exempt Bond Index Fund worth $431K.

  • O'Rourke & Company's largest Q2 2022 buy was Vanguard Tax-Exempt Bond Index Fund: 8,643 shares worth $431K.
  • O'Rourke & Company added most to Vanguard Morningstar Small-Cap Value ETF in Q2 2022, an estimated $253K increase.
  • O'Rourke & Company's biggest Q2 2022 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $1.59M.
  • O'Rourke & Company fully exited Coinbase in Q2 2022, selling an estimated $510K.
  • O'Rourke & Company's ten largest holdings make up 42% of its $118M portfolio in Q2 2022.
  • O'Rourke & Company opened 4 new positions and closed 12 in Q2 2022.
  • O'Rourke & Company's portfolio value fell 19% quarter-over-quarter to $118M.

Based on O'Rourke & Company's 13F filing for Q2 2022, filed 12 Aug 2022.